Table 2.
Variable | Value | |
---|---|---|
Year of cystectomy, n (%) | ||
2008 | 23 (9.0) | |
2009 | 14 (5.5) | |
2010 | 14 (5.5) | |
2011 | 18 (7.1) | |
2012 | 30 (11.8) | |
2013 | 16 (6.3) | |
2014 | 43 (16.9) | |
2015 | 97 (38.0) | |
Extension of LND | ||
Not performed | 50 (19.6) | |
Limited | 141 (55.3) | |
Extended | 49 (19.2) | |
Super-extended | 15 (5.9) | |
Overall LNs removed, n, median (IQR) | 13 (7–21) | |
Overall positive LNs, n (%) 0 1 |
157 (61.6) 35 (13.7) |
|
2 | 18 (7.1) | |
>2 | 45 (17.6) | |
Pathological T-stage at RC, n (%) | ||
T1 | 15 (5.9) | |
T2 | 67 (26.3) | |
T3 | 117 (45.9) | |
T4 | 56 (22.0) | |
Pathological N-stage at RC, n (%) | ||
Nx | 49 (18.6) | |
N0 | 108 (40.9) | |
N1 | 35 (13.3) | |
N2 | 36 (13.6) | |
N3 | 27 (10.2) | |
Concomitant CIS, n (%) | 98 (38.4) | |
Concomitant LVI, n (%) | 71 (27.8) | |
Overall postoperative complications, n (%) | 107 (41.9) | |
Clavien–Dindo Grade I, n (%) | 52 (20.4) | |
Clavien–Dindo Grade II, n (%) | 19 (7.5) | |
Major | Clavien–Dindo Grade IIIa, n (%) | 11 (4.3) |
Clavien–Dindo Grade IIIb, n (%) | 10 (3.9) | |
Clavien–Dindo Grade IV, n (%) | 7 (2.7) | |
Clavien–Dindo Grade V, n (%) | 8 (3.1) |